Last updated on October 2016

Study of Pre-operative Combination Therapy With Mogamulizumab and Nivolumab Against Solid Cancer Patients


Brief description of study

To assess the safety of preoperative combination therapy with KW-0761 (anti-CCR4) and ONO-4538 (anti-PD-1). To assess the behavior of immune cells in peripheral blood and tumor.

Clinical Study Identifier: NCT02946671

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Hisashi Wada

Osaka University
Suita, Japan
  Connect »